The overall accuracy of this diagnostic approach is reported to be 86.3%.26 In the case of very early Barcelona Clinic Liver Cancer (BCLC 0) and early (BCLCA) HCC, the percentage of DCP (55.6% and 61.1%, respectively) was significantly higher than AFP (22.2% and 16.7%, respectively). This evidence concerns the gene AFP and hepatocellular carcinoma.